Publication | Closed Access

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

Fludarabine/busulfan-based Reduced-intensity ConditioningHematological MalignancyTransplantationMarrow TransplantationMyelodysplastic SyndromeMixed-phenotype Acute LeukemiaStem Cell TransplantationHematologyCell TransplantationMedicineRadiation OncologyHealth Sciences